Who owns Dianthus Therapeutics, Inc. /DE/?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of DNTH from SEC Form 13F filings across 270 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 270 institutions disclosed 65.7M shares of Dianthus Therapeutics, Inc. /DE/ worth $6.39B — about 117.2% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
270
13F holders
$6.39B
value, 2026 filers
117.2%
of shares outstanding (65.7M sh)
64
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of DNTH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 8.2M | $799.3M | 0.0% | 14.6% | +5.6% |
| 2 | BlackRock, Inc. | 4.1M | $402.0M | 0.0% | 7.4% | +29.9% |
| 3 | T. Rowe Price Investment Management, Inc. | 3.9M | $379.0M | 0.2% | 6.9% | +200.9% |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 3.2M | $314.8M | 0.1% | 5.8% | +24.4% |
| 5 | Fairmount Funds Management LLC | 2.5M | $247.3M | 16.3% | 4.5% | 0.0% |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.5M | $245.2M | 0.0% | 4.5% | +119.3% |
| 7 | STATE STREET CORP | 2.4M | $229.8M | 0.0% | 4.2% | +68.5% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $210.5M | 0.0% | 3.9% | +6.3% |
| 9 | Avidity Partners Management LP | 2.1M | $205.1M | 32.8% | 3.8% | 0.0% |
| 10 | Octagon Capital Advisors LP | 1.8M | $179.5M | 16.1% | 3.3% | -5.4% |
| 11 | TCG Crossover Management, LLC | 1.7M | $163.4M | 3.9% | 3% | 0.0% |
| 12 | FRED ALGER MANAGEMENT, LLC | 1.3M | $127.0M | 0.4% | 2.3% | +12.1% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $122.7M | 0.0% | 2.2% | +37.4% |
| 14 | Venrock Adviser, LLC | 1.2M | $115.0M | 3.5% | 2.1% | 0.0% |
| 15 | UBS Group AG | 1.1M | $111.2M | 0.0% | 2% | +45.9% |
| 16 | DEERFIELD MANAGEMENT COMPANY, L.P. | 1.1M | $109.7M | 1.1% | 2% | +10.3% |
| 17 | JENNISON ASSOCIATES LLC | 1.0M | $99.6M | 0.1% | 1.8% | +110.6% |
| 18 | Polar Capital Holdings Plc | 1.0M | $99.3M | 0.2% | 1.8% | -5.3% |
| 19 | CITADEL ADVISORS LLC | 974,911 | $95.0M | 0.0% | 1.7% | -39.5% |
| 20 | FRANKLIN RESOURCES INC | 968,983 | $94.5M | 0.0% | 1.7% | +0.1% |
| 21 | BAKER BROS. ADVISORS LP | 852,164 | $83.1M | 0.4% | 1.5% | 0.0% |
| 22 | ALLIANCEBERNSTEIN L.P. | 834,150 | $70.0M | 0.0% | 1.5% | -9.9% |
| 23 | Logos Global Management LP | 800,000 | $78.0M | 3.4% | 1.4% | +100.0% |
| 24 | Cormorant Asset Management, LP | 750,000 | $73.1M | 3.7% | 1.3% | -21.1% |
| 25 | BRAIDWELL LP | 594,562 | $58.0M | 2.1% | 1.1% | -33.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.